合成生物学与纳米生物学的交叉融合及其在生物医药领域的应用

郑涵奇; 吴晴; 李洪军; 顾臻

doi:10.12211/2096-8280.2022-008

您当前的位置：

首页 >

文章列表页 >

合成生物学与纳米生物学的交叉融合及其在生物医药领域的应用

特约评述 | 更新时间：2025-03-20

- 合成生物学与纳米生物学的交叉融合及其在生物医药领域的应用
- Integration of synthetic biology and nanobiotechnology for biomedical applications
- 合成生物学 2022年3卷第2期页码：279-301
- 作者机构：
  
  1.浙江省先进递药系统重点实验室，浙江大学药学院，浙江杭州 310058
  2.浙江省系统与精准医学实验室，良渚实验室，浙江大学医学中心，浙江杭州 311121
  3.浙江大学医学院附属邵逸夫医院，普外科，浙江杭州 310016
  4.高分子合成与功能化教育部重点实验室，浙江大学高分子科学与工程系，浙江杭州 310027
- 作者简介：
  
  [ "郑涵奇（2000—），男，硕士研究生。研究方向为新型工程化免疫细胞及其在肿瘤免疫治疗中的应用。 E-mail：zhenghanqi@zju.edu.cn" ]
  [ "李洪军（1989—），男，浙江大学特聘研究员，博士生导师。研究方向包括新型工程化免疫细胞用于肿瘤免疫治疗的开发、智能型药物递送系统/器件的开发等。 E-mail：hongjun@zju.edu.cn" ]
  [ "顾臻（1980—），男，浙江大学求是讲席教授、药学院院长，教育部“长江学者”讲席教授，浙江省先进递药系统重点实验室主任，国家重点研发计划项目首席科学家，博士生导师。研究方向包括蛋白质/核酸递药系统、生理响应材料、免疫治疗制剂、细胞治疗策略等。 E-mail：guzhen@zju.edu.cn" ]
- 基金信息：
  
  国家重点研发计划(2021YFA0909900);国家自然科学基金(52173142);浙江大学科研启动经费
- DOI：10.12211/2096-8280.2022-008
  中图分类号： Q 819
- 收稿：2022-01-27，
  
  修回：2022-02-21，
  
  纸质出版：2022-04-30
- 稿件说明：
移动端阅览
郑涵奇，吴晴，李洪军，顾臻. 合成生物学与纳米生物学的交叉融合及其在生物医药领域的应用［J］. 合成生物学， 2022， 3（2）： 279-301

ZHENG Hanqi， WU Qing， LI Hongjun， GU Zhen. Integration of synthetic biology and nanobiotechnology for biomedical applications［J］. Synthetic Biology Journal， 2022， 3（2）： 279-301
郑涵奇，吴晴，李洪军，顾臻. 合成生物学与纳米生物学的交叉融合及其在生物医药领域的应用［J］. 合成生物学， 2022， 3（2）： 279-301 DOI： 10.12211/2096-8280.2022-008.

ZHENG Hanqi， WU Qing， LI Hongjun， GU Zhen. Integration of synthetic biology and nanobiotechnology for biomedical applications［J］. Synthetic Biology Journal， 2022， 3（2）： 279-301 DOI： 10.12211/2096-8280.2022-008.

摘要

合成生物学与纳米生物学的交叉融合业已成为促进生物技术与生物医药领域发展的重要方向之一。利用合成生物学技术可以帮助生物源性纳米材料创造特殊的结构与功能，驱动纳米生物学的发展。纳米技术的应用则可助力基因线路递送，提升基于合成生物学的生产效率；参与介导基因调控，拓展合成生物学技术的应用场景。合成生物学和纳米生物学的融合可以构建出纳米级功能模块和纳米人工杂合系统，增强改造后体系的功能。本文将着重介绍近期合成生物学和纳米生物学交叉融合的相关研究进展，从纳米技术为合成生物学的发展赋能、合成生物学成为助力纳米技术应用的新引擎以及合成生物学和纳米生物学融合发展这三个角度，着重阐述该领域近期的重点工作，剖析并展望相关技术在基因编辑、药物递送以及医学成像等生物医药领域的应用和前景。未来，合成生物学和纳米生物学的交叉融合可能朝着模块化、标准化、仿生化、功能集成化和智能化的方向进一步发展，为生物医药领域带来新的突破。

Abstract

Synthetic biology aims at designing

transforming

and even re-synthesizing living organisms with specific functions. Nanobiotechnology is devoted to solving major biological problems through drug delivery and disease diagnosis and intervention by utilizing the unique physical

chemical and biological properties of substances at micro-and nano-scales. The integration of synthetic biology and nanobiotechnology promotes the fundamental and clinical development of biomedical science and biotechnology. Nanomaterials obtained through synthetic biology technology could be endowed with unique structures and functions

facilitating the advances of nanobiology. The application of nanotechnology can expand the application scenarios of synthetic biotechnology

improve the production efficiency of target compounds

and enhance the functions of modified organisms. This review focuses on the recent research progress in the interdisciplinary field of synthetic biology and nanobiotechnology from three perspectives

including (1) how can nanotechnology reinforce the development of synthetic biology? (2) how can synthetic biology extend the applications of nanotechnology? (3) how can synthetic biology and nanobiology jointly work to bring in new techniques? Specifically

the nanocarriers can enhance the delivery efficiency of synthetic gene circuits and genome editing agents. The ability to realize the signal transduction of nanoparticles can enable the spatiotemporal control of gene expression

via

minimally invasive manipulations. The biologic nano-agents strengthened by genetic engineering have been developed

such as

the programmed cell-derived particles

including exosomes

microvesicles

and membrane-derived particles. Under the guidance of the philosophy of synthetic biology

modular functional nanocomponents can be formulated by self-assembly on the basis of nucleic acids

proteins

lipids

polymers

and inorganic materials. The nanodevices and engineered biological chassis can benefit the hybrid system through taking advantage of both sides. Furthermore

we also discuss the applications and prospects of related technologies mentioned above in genome editing

drug delivery

diseases diagnosis

and other biomedical fields. At the disciplinary crossroad

the integration of synthetic biology and nanobiotechnology can drive towards modularization

standardization

bioinspiration

functional integration

and intelligentization for next-generation biomedical breakthroughs.

Representative examples for the integration of synthetic biology and nanobiotechnology. Nanotechnology can reinforce the development of synthetic biology by promoting the design and delivery of gene circuits. The delivery of gene circuits can be facilitated by nanocarriers

including organic (a)

inorganic (b)

and bionic (c) systems. Nanoparticles can convert optical

magnetic

and acoustic signals to thermal signals to regulate gene expression (d). Synthetic biology can extend the applications of nanotechnology through genetically engineering biologic nano-agents. Platelets (e)

exosomes (f)

microvesicles (g)

and membrane-derived vesicles (h) can be programmed through synthetic biology. Synthetic biology and nanobiology can jointly generate functional modules and hybrid systems for artificial biomimetic systems. DNA

lipids

and polymers can self-assemble into functional modules (i)

and nanoparticles can be combined with chimeric antigen receptor T-cells and bacteria respectively to form hybrid systems (j).

关键词

Keywords

references

BENNER S A , SISMOUR A M . Synthetic biology [J ] . Nature Reviews Genetics , 2005 , 6 ( 7 ): 533 - 543 .

OMIDVAR R , AYALA Y A , BRANDEL A , et al . Quantification of nanoscale forces in lectin-mediated bacterial attachment and uptake into giant liposomes [J ] . Nanoscale , 2021 , 13 ( 7 ): 4016 - 4028 .

ENDY D . Foundations for engineering biology [J ] . Nature , 2005 , 438 ( 7067 ): 449 - 453 .

XIE M , FUSSENEGGER M . Designing cell function: assembly of synthetic gene circuits for cell biology applications [J ] . Nature Reviews Molecular Cell Biology , 2018 , 19 ( 8 ): 507 - 525 .

JUSIAK B , CLETO S , PEREZ-PIÑERA P , et al . Engineering synthetic gene circuits in living cells with CRISPR technology [J ] . Trends in Biotechnology , 2016 , 34 ( 7 ): 535 - 547 .

CHURCH G M , ELOWITZ M B , SMOLKE C D , et al . Realizing the potential of synthetic biology [J ] . Nature Reviews Molecular Cell Biology , 2014 , 15 ( 4 ): 289 - 294 .

ORIVE G , GASCÓN A R , HERNÁNDEZ R M , et al . Techniques: new approaches to the delivery of biopharmaceuticals [J ] . Trends in Pharmacological Sciences , 2004 , 25 ( 7 ): 382 - 387 .

RAZZACKI S Z , THWAR P K , YANG M , et al . Integrated microsystems for controlled drug delivery [J ] . Advanced Drug Delivery Reviews , 2004 , 56 ( 2 ): 185 - 198 .

JAHANGIRIAN H , LEMRASKI E G , WEBSTER T J , et al . A review of drug delivery systems based on nanotechnology and green chemistry: Green nanomedicine [J ] . International Journal of Nanomedicine , 2017 , 12 : 2957 - 2978 .

PATRA J K , DAS G , FRACETO L F , et al . Nano based drug delivery systems: recent developments and future prospects [J ] . Journal of Nanobiotechnology , 2018 , 16 ( 1 ): 71 .

CHOI Y , PARK T J , LEE D C , et al . Recombinant Escherichia coli as a biofactory for various single- and multi-element nanomaterials [J ] . Proceedings of the National Academy of Sciences of the United States of America , 2018 , 115 ( 23 ): 5944 - 5949 .

IRAVANI S , VARMA R S . Biofactories: engineered nanoparticles via genetically engineered organisms [J ] . Green Chemistry , 2019 , 21 ( 17 ): 4583 - 4603 .

JAHROMI L P , FUHRMANN G . Bacterial extracellular vesicles: understanding biology promotes applications as nanopharmaceuticals [J ] . Advanced Drug Delivery Reviews , 2021 , 173 : 125 - 140 .

冯晴晴 , 张天鲛 , 赵潇 , 等 . 合成纳米生物学——合成生物学与纳米生物学的交叉前沿 [J ] . 合成生物学 , 2022 , 3 ( 2 ): 260 - 278 .

FENG Qingqing , ZHANG Tianjiao , ZHAO Xiao , et al . Synthetic nanobiology——fusion of synthetic biology and nanobiology. Synthetic Biology Journal [J ] , 2022 , 3 ( 2 ): 260 - 278 .

CHANNON K , BROMLEY E H , WOOLFSON D N . Synthetic biology through biomolecular design and engineering [J ] . Current Opinion in Structural Biology , 2008 , 18 ( 4 ): 491 - 498 .

KIM J K , YANG S Y , LEE Y , et al . Functional nanomaterials based on block copolymer self-assembly [J ] . Progress in Polymer Science , 2010 , 35 ( 11 ): 1325 - 1349 .

GAUR D , DUBEY N C , TRIPATHI B P . Biocatalytic self-assembled synthetic vesicles and coacervates: from single compartment to artificial cells [J ] . Advances in Colloid and Interface Science , 2022 , 299 : 102566 .

TABEBORDBAR M , ZHU K X , CHENG J K W , et al . In vivo gene editing in dystrophic mouse muscle and muscle stem cells [J ] . Science , 2016 , 351 ( 6271 ): 407 - 411 .

LONG C Z , AMOASII L , MIREAULT A A , et al . Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy [J ] . Science , 2016 , 351 ( 6271 ): 400 - 403 .

NELSON C E , HAKIM C H , OUSTEROUT D G , et al . In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy [J ] . Science , 2016 , 351 ( 6271 ): 403 - 407 .

WANG D , ZHANG F , GAO G P . CRISPR-based therapeutic genome editing: strategies and in vivo delivery by AAV vectors [J ] . Cell , 2020 , 181 ( 1 ): 136 - 150 .

WANG H X , LI M Q , LEE C M , et al . CRISPR/Cas9-based genome editing for disease modeling and therapy: challenges and opportunities for nonviral delivery [J ] . Chemical Reviews , 2017 , 117 ( 15 ): 9874 - 9906 .

LATTANZI A , MENEGHINI V , PAVANI G , et al . Optimization of CRISPR/Cas9 delivery to human hematopoietic stem and progenitor cells for therapeutic genomic rearrangements [J ] . Molecular Therapy , 2019 , 27 ( 1 ): 137 - 150 .

WILBIE D , WALTHER J , MASTROBATTISTA E . Delivery aspects of CRISPR/cas for in vivo genome editing [J ] . Accounts of Chemical Research , 2019 , 52 ( 6 ): 1555 - 1564 .

RAN F A , HSU P D , WRIGHT J , et al . Genome engineering using the CRISPR-Cas9 system [J ] . Nature Protocols , 2013 , 8 ( 11 ): 2281 - 2308 .

NIU Y Y , SHEN B , CUI Y Q , et al . Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos [J ] . Cell , 2014 , 156 ( 4 ): 836 - 843 .

ZURIS J A , THOMPSON D B , SHU Y L , et al . Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo [J ] . Nature Biotechnology , 2015 , 33 ( 1 ): 73 - 80 .

SUN W J , JI W Y , HALL J M , et al . Efficient delivery of CRISPR-Cas9 for genome editing via self-assembled DNA nanoclews [J ] . Angewandte Chemie International Edition , 2015 , 54 ( 41 ): 12029 - 33 .

SUN W J , WANG J Q , HU Q Y , et al . CRISPR-Cas12a delivery by DNA-mediated bioresponsive editing for cholesterol regulation [J ] . Science Advances , 2020 , 6 ( 21 ): eaba2983 .

SHIN M D , SHUKLA S , CHUNG Y H , et al . COVID-19 vaccine development and a potential nanomaterial path forward [J ] . Nature Nanotechnology , 2020 , 15 ( 8 ): 646 - 655 .

PATEL S , ASHWANIKUMAR N , ROBINSON E , et al . Boosting intracellular delivery of lipid nanoparticle-encapsulated mRNA [J ] . Nano Letters , 2017 , 17 ( 9 ): 5711 - 5718 .

TANG Q , LIU J , JIANG Y , et al . Cell-selective messenger RNA delivery and CRISPR/Cas9 genome editing by modulating the interface of phenylboronic acid-derived lipid nanoparticles and cellular surface sialic acid [J ] . ACS Applied Materials & Interfaces , 2019 , 11 ( 50 ): 46585 - 46590 .

ZHANG S , SHEN J T , LI D L , et al . Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing [J ] . Theranostics , 2021 , 11 ( 2 ): 614 - 648 .

GAO X , TAO Y , LAMAS V , et al . Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents [J ] . Nature , 2018 , 553 ( 7687 ): 217 - 221 .

CHO E Y , RYU J Y , LEE H , et al . Lecithin nano-liposomal particle as a CRISPR/Cas9 complex delivery system for treating type 2 diabetes [J ] . Journal of Nanobiotechnology , 2019 , 17 ( 1 ): 19 .

MILLER J B , ZHANG S Y , KOS P , et al . Non-viral CRISPR/cas gene editing in vitro and in vivo enabled by synthetic nanoparticle co-delivery of Cas9 mRNA and sgRNA [J ] . Angewandte Chemie International Edition , 2017 , 56 ( 4 ): 1059 - 1063 .

LI C H , YANG T R , WENG Y H , et al . Ionizable lipid-assisted efficient hepatic delivery of gene editing elements for oncotherapy [J ] . Bioactive Materials , 2022 , 9 : 590 - 601 .

FINN J D , SMITH A R , PATEL M C , et al . A single administration of CRISPR/Cas9 lipid nanoparticles achieves robust and persistent in vivo genome editing [J ] . Cell Reports , 2018 , 22 ( 9 ): 2227 - 2235 .

FU A L , TANG R , HARDIE J , et al . Promises and pitfalls of intracellular delivery of proteins [J ] . Bioconjugate Chemistry , 2014 , 25 ( 9 ): 1602 - 1608 .

LIU J , CHANG J , JIANG Y , et al . Fast and efficie nt CRISPR/Cas9 genome editing in vivo enabled by bioreducible lipid and messenger RNA nanoparticles [J ] . Advanced Materials (Deerfield Beach, Fla) , 2019 , 31 ( 33 ): e1902575 .

WANG M , ZURIS J A , MENG F T , et al . Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles [J ] . PNAS , 2016 , 113 ( 11 ): 2868 - 2873 .

WANG K , SHANG F S , CHEN D G , et al . Protein liposomes-mediated targeted acetylcholinesterase gene delivery for effective liver cancer therapy [J ] . Journal of Nanobiotechnology , 2021 , 19 ( 1 ): 31 .

CHENG Q , WEI T , FARBIAK L , et al . Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing [J ] . Nature Nanotechnology , 2020 , 15 ( 4 ): 313 - 320 .

WANG W W , BALK M , DENG Z J , et al . Engineering biodegradable micelles of polyethylenimine-based amphiphilic block copolymers for efficient DNA and siRNA delivery [J ] . Journal of Controlled Release , 2016 , 242 : 71 - 79 .

SHEN J , LU Z G , WANG J Z , et al . Traceable nano-biohybrid complexes by one-step synthesis as CRISPR-chem vectors for neurodegenerative diseases synergistic treatment [J ] . Advanced Materials , 2021 , 33 ( 27 ): 2101993 .

FANG H P , CHEN J , LIN L , et al . A strategy of killing three birds with one stone for cancer therapy through regulating the tumor microenvironment by H 2 O 2 -responsive gene delivery system [J ] . ACS Applied Materials & Interfaces , 2019 , 11 ( 51 ): 47785 - 47797 .

SHARMA R , ZHANG I , SHIAO T C , et al . Low generation polyamine dendrimers bearing flexible tetraethylene glycol as nanocarriers for plasmids and siRNA [J ] . Nanoscale , 2016 , 8 ( 9 ): 5106 - 5119 .

RUI Y , WILSON D R , CHOI J , et al . Carboxylated branched poly ( β -amino ester) nanoparticles enable robust cytosolic protein delivery and CRISPR-Cas9 gene editing [J ] . Science Advances , 2019 , 5 ( 12 ): eaay3255 .

XU X D , WU J , LIU Y L , et al . Ultra-pH-responsive and tumor-penetrating nanoplatform for targeted siRNA delivery with robust anti-cancer efficacy [J ] . Angewandte Chemie International Edition , 2016 , 128 ( 25 ): 7207 - 7210 .

LAO Y H , LI M Q , GAO M A , et al . HPV oncogene manipulation using nonvirally delivered CRISPR/Cas9 or natronobacterium gregoryi argonaute [J ] . Advanced Science , 2018 , 5 ( 7 ): 1700540 .

QI Y , SONG H Q , XIAO H H , et al . Fluorinated acid-labile branched hydroxyl-rich nanosystems for flexible and robust delivery of plasmids [J ] . Small , 2018 , 14 ( 42 ): 1803061 .

QI Y , LIU Y L , YU B R , et al . A lactose-derived CRISPR/Cas9 delivery system for efficient genome editing in vivo to treat orthotopic hepatocellular carcinoma [J ] . Advanced Science , 2020 , 7 ( 17 ): 2001424 .

WANG H X , SONG Z Y , LAO Y H , et al . Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide [J ] . Proceedings of the National Academy of Sciences of the United States of America , 2018 , 115 ( 19 ): 4903 - 4908 .

GUO J J , WAN T , LI B W , et al . Rational design of poly(disulfide) s as a universal platform for delivery of CRISPR-Cas9 machineries toward therapeutic genome editing [J ] . ACS Central Science , 2021 , 7 ( 6 ): 990 - 1000 .

WANG F , GAO J Y , XIAO J G , et al . Dually gated polymersomes for gene delivery [J ] . Nano Letters , 2018 , 18 ( 9 ): 5562 - 5568 .

VEIMAN K L , KÜNNAPUU K , LEHTO T , et al . PEG shielded MMP sensitive CPPs for efficient and tumor specific gene delivery in vivo [J ] . Journal of Controlled Release , 2015 , 209 : 238 - 247 .

LIU C , WANG N , LUO R , et al . A programmable hierarchical-responsive nanoCRISPR elicits robust activation of endogenous target to treat cancer [J ] . Theranostics , 2021 , 11 ( 20 ): 9833 - 9846 .

WANG H X , YANG X Z , SUN C Y , et al . Matrix metalloproteinase 2-responsive micelle for siRNA delivery [J ] . Biomaterials , 2014 , 35 ( 26 ): 7622 - 7634 .

CHEN Z M , LIU F Y , CHEN Y K , et al . Targeted delivery of CRISPR/Cas9-mediated cancer gene therapy via liposome-templated hydrogel nanoparticles [J ] . Advanced Functional Materials , 2017 , 27 ( 46 ): 1703036 .

LI L , SONG L J , LIU X W , et al . Artificial virus delivers CRISPR-Cas9 system for genome editing of cells in mice [J ] . ACS Nano , 2017 , 11 ( 1 ): 95 - 111 .

WILLIFORD J M , WU J , REN Y , et al . Recent advances in nanoparticle-mediated siRNA delivery [J ] . Annual Review of Biomedical Engineering , 2014 , 16 : 347 - 370 .

ANSELMO A C , MITRAGOTRI S . Nanoparticles in the clinic [J ] . Bioengineering & Translational Medicine , 2016 , 1 ( 1 ): 10 - 29 .

LEE Y W , LUTHER D C , KRETZMANN J A , et al . Protein delivery into the cell cytosol using non-viral nanocarriers [J ] . Theranostics , 2019 , 9 ( 11 ): 3280 - 3292 .

WANG P , ZHANG L M , XIE Y , et al . Genome editing for cancer therapy: delivery of Cas9 protein/sgRNA plasmid via a gold nanocluster/lipid core-shell nanocarrier [J ] . Advanced Science , 2017 , 4 ( 11 ): 1700175 .

MOUT R , RAY M , YESILBAG TONGA G , et al . Direct cytosolic delivery of CRISPR/Cas9-ribonucleoprotein for efficient gene editing [J ] . ACS Nano , 2017 , 11 ( 3 ): 2452 - 2458 .

LEE K , CONBOY M , PARK H M , et al . Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair [J ] . Nature Biomedical Engineering , 2017 , 1 ( 11 ): 889 - 901 .

LEE B , LEE K , PANDA S , et al . Nanoparticle delivery of CRISPR into the brain rescues a mouse model of fragile X syndrome from exaggerated repetitive behaviours [J ] . Nature Biomedical Engineering , 2018 , 2 ( 7 ): 497 - 507 .

YANG Y M , HAN Y , SUN Q Y , et al . Au-siRNA@ aptamer nanocages as a high-efficiency drug and gene delivery system for targeted lung cancer therapy [J ] . Journal of Nanobiotechnology , 2021 , 19 ( 1 ): 54 .

SHAHBAZI R , SGHIA-HUGHES G , REID J L , et al . Targeted homology-directed repair in blood stem and progenitor cells with CRISPR nanoformulations [J ] . Nature Materials , 2019 , 18 ( 10 ): 1124 - 1132 .

WANG P , ZHANG L M , ZHENG W F , et al . Thermo-triggered release of CRISPR-Cas9 system by lipid-encapsulated gold nanoparticles for tumor therapy [J ] . Angewandte Chemie International Edition , 2018 , 130 ( 6 ): 1507 - 1512 .

PAN Y C , YANG J J , LUAN X W , et al . Near-infrared upconversion-activated CRISPR-Cas9 system: a remote-controlled gene editing platform [J ] . Science Advances , 2019 , 5 ( 4 ): eaav7199 .

PODDAR A , CONESA J J , LIANG K , et al . Encapsulation, visualization and expression of genes with biomimetically mineralized zeolitic imidazolate framework-8 (ZIF-8) [J ] . Small , 2019 , 15 ( 36 ): 1902268 .

ALYAMI M Z , ALSAIARI S K , LI Y Y , et al . Cell-type-specific CRISPR/Cas9 delivery by biomimetic metal organic frameworks [J ] . Journal of the American Chemical Society , 2020 , 142 ( 4 ): 1715 - 1720 .

ALSAIARI S K , PATIL S , ALYAMI M , et al . Endosomal escape and delivery of CRISPR/Cas9 genome editing machinery enabled by nanoscale zeolitic imidazolate framework [J ] . Journal of the American Chemical Society , 2018 , 140 ( 1 ): 143 - 146 .

WANG Y Y , SHAHI P K , XIE R S , et al . A pH-responsive silica-metal-organic framework hybrid nanoparticle for the delivery of hydrophilic drugs, nucleic acids, and CRISPR-Cas9 genome-editing machineries [J ] . Journal of Controlled Release , 2020 , 324 : 194 - 203 .

YANG X T , TANG Q , JIANG Y , et al . Nanoscale ATP-responsive zeolitic imidazole framework-90 as a general platform for cytosolic protein delivery and genome editing [J ] . Journal of the American Chemical Society , 2019 , 141 ( 9 ): 3782 - 3786 .

YUE H H , ZHOU X M , CHENG M , et al . Graphene oxide-mediated Cas9/sgRNA delivery for efficient genome editing [J ] . Nanoscale , 2018 , 10 ( 3 ): 1063 - 1071 .

SALEKDEH P R , MA'MANI L , TAVAKKOLY-BAZZAZ J , et al . Bi-functionalized aminoguanidine-PEGylated periodic mesoporous organosilica nanoparticles: a promising nanocarrier for delivery of Cas9-sgRNA ribonucleoproteine [J ] . Journal of Nanobiotechnology , 2021 , 19 ( 1 ): 95 .

LIU B , EJAZ W , GONG S , et al . Engineered interactions with mesoporous silica facilitate intracellular delivery of proteins and gene editing [J ] . Nano Letters , 2020 , 20 ( 5 ): 4014 - 4021 .

ZHOU W H , CUI H D , YING L M , et al . Enhanced cytosolic delivery and release of CRISPR/Cas9 by black phosphorus nanosheets for genome editing [J ] . Angewandte Chemie International Edition , 2018 , 130 ( 32 ): 10425 - 10429 .

LI S J , SONG Z Y , LIU C Y , et al . Biomimetic mineralization-based CRISPR/Cas9 ribonucleoprotein nanoparticles for gene editing [J ] . ACS Applied Materials & Interfaces , 2019 , 11 ( 51 ): 47762 - 47770 .

HAN X , XU X , WU Z H , et al . Synchronous conjugation of i-motif DNA and therapeutic siRNA on the vertexes of tetrahedral DNA nanocages for efficient gene silence [J ] . Acta Pharmaceutica Sinica B , 2021 , 11 ( 10 ): 3286 - 3296 .

MITCHELL M J , BILLINGSLEY M M , HALEY R M , et al . Engineering precision nanoparticles for drug delivery [J ] . Nature Reviews Drug Discovery , 2021 , 20 ( 2 ): 101 - 124 .

KANETI L , BRONSHTEIN T , MALKAH DAYAN N , et al . Nanoghosts as a novel natural nonviral gene delivery platform safely targeting multiple cancers [J ] . Nano Letters , 2016 , 16 ( 3 ): 1574 - 1582 .

LIN Y , WU J H , GU W H , et al . Exosome-liposome hybrid nanoparticles deliver CRISPR/Cas9 system in MSCs [J ] . Advanced Science , 2018 , 5 ( 4 ): 1700611 .

LU M , ZHAO X Y , XING H N , et al . Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery [J ] . Acta Biomaterialia , 2019 , 96 : 517 - 536 .

LÜ P , JAVIDI-PARSIJANI P , ATALA A , et al . Delivering Cas9/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient 'hit-and-Run' genome editing [J ] . Nucleic Acids Research , 2019 , 47 ( 17 ): e99 .

MANGEOT P E , RISSON V , FUSIL F , et al . Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins [J ] . Nature Communications , 2019 , 10 : 45 .

KAMERKAR S , LEBLEU V S , SUGIMOTO H , et al . Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer [J ] . Nature , 2017 , 546 ( 7659 ): 498 - 503 .

XU Q , ZHANG Z , ZHAO L , et al . Tropism-facilitated delivery of CRISPR/Cas9 system with chimeric antigen receptor-extracellular vesicles against B-cell malignancies [J ] . Journal of Controlled Release , 2020 , 326 : 455 - 467 .

WANG Q Y , YU J J , KADUNGURE T , et al . ARMMs as a versatile platform for intracellular delivery of macromolecules [J ] . Nature Communications , 2018 , 9 : 960 .

GEE P , LUNG M S Y , OKUZAKI Y , et al . Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping [J ] . Nature Communications , 2020 , 11 : 1334 .

ZHUANG J L , TAN J Z , WU C L , et al . Extracellular vesicles engineered with valency-controlled DNA nanostructures deliver CRISPR/Cas9 system for gene therapy [J ] . Nucleic Acids Research , 2020 , 48 ( 16 ): 8870 - 8882 .

REN K , LIU Y , WU J , et al . A DNA dual lock-and-key strategy for cell-subtype-specific siRNA delivery [J ] . Nature Communications , 2016 , 7 : 13580 .

HERRMANN I K , WOOD M J A , FUHRMANN G . Extracellular vesicles as a next-generation drug delivery platform [J ] . Nature Nanotechnology , 2021 , 16 ( 7 ): 748 - 759 .

CULLY M . Exosome-based candidates move into the clinic [J ] . Nature Reviews Drug Discovery , 2021 , 20 ( 1 ): 6 - 7 .

AUSLÄNDER S , FUSSENEGGER M . Engineering gene circuits for mammalian cell-based applications [J ] . Cold Spring Harbor Perspectives in Biology , 2016 , 8 ( 7 ): a023895 .

ARATBONI H A , RAFIEI N , KHORASHAD L K , et al . LED control of gene expression in a nanobiosystem composed of metallic nanoparticles and a genetically modified E. coli strain [J ] . Journal of Nanobiotechnology , 2021 , 19 ( 1 ): 190 .

HASTY J , PRADINES J , DOLNIK M , et al . Noise-based switches and amplifiers for gene expression [J ] . Proceedings of the National Academy of Sciences of the United States of America , 2000 , 97 ( 5 ): 2075 - 2080 .

TANG Q S , ZHANG D S , CONG X M , et al . Using thermal energy produced by irradiation of Mn-Zn ferrite magnetic nanoparticles (MZF-NPs) for heat-inducible gene expression [J ] . Biomaterials , 2008 , 29 ( 17 ): 2673 - 2679 .

ORTNER V , KASPAR C , HALTER C , et al . Magnetic field-controlled gene expression in encapsulated cells [J ] . Journal of Controlled Release , 2012 , 158 ( 3 ): 424 - 432 .

YAMAGUCHI M , ITO A , ONO A , et al . Heat-inducible gene expression system by applying alternating magnetic field to magnetic nanoparticles [J ] . ACS Synthetic Biology , 2014 , 3 ( 5 ): 273 - 279 .

LÜ Y , CUI D , SUN H , et al . Dendronized semiconducting polymer as photothermal nanocarrier for remote activation of gene expression [J ] . Angewandte Chemie International Edition , 2017 , 56 ( 31 ): 9155 - 9159 .

WANG Y X , LI S L , ZHANG P B , et al . Photothermal-responsive conjugated polymer nanoparticles for remote control of gene expression in living cells [J ] . Advanced Materials , 2018 , 30 ( 8 ): 1705418 .

BAKHTIARI A , HSIAO D , JIN G X , et al . An efficient method based on the photothermal effect for the release of molecules from metal nanoparticle surfaces [J ] . Angewandte Chemie International Edition , 2009 , 48 ( 23 ): 4166 - 4169 .

TAN S W , WU T T , ZHANG D , et al . Cell or cell membrane-based drug delivery systems [J ] . Theranostics , 2015 , 5 ( 8 ): 863 - 881 .

REN E , LIU C , LV P , et al . Genetically engineered cellular membrane vesicles as tailorable shells for therapeutics [J ] . Advanced Science , 2021 , 8 ( 21 ): 2100460 .

VAN NIEL G , D'ANGELO G , RAPOSO G . Shedding light on the cell biology of extracellular vesicles [J ] . Nature Reviews Molecular Cell Biology , 2018 , 19 ( 4 ): 213 - 228 .

SHI X J , CHENG Q Q , HOU T L , et al . Genetically engineered cell-derived nanoparticles for targeted breast cancer immunotherapy [J ] . Molecular Therapy , 2020 , 28 ( 2 ): 536 - 547 .

SU D D , TSAI H I , XU Z X , et al . Exosomal PD-L1 functions as an immunosuppressant to promote wound healing [J ] . Journal of Extracellular Vesicles , 2020 , 9 ( 1 ): 1709262 .

SHELLER-MILLER S , RADNAA E , YOO J K , et al . Exosomal delivery of NF-κB inhibitor delays LPS-induced preterm birth and modulates fetal immune cell profile in mouse models [J ] . Science Advances , 2021 , 7 ( 4 ): eabd3865 .

KOJIMA R , BOJAR D , RIZZI G , et al . Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson's disease treatment [J ] . Nature Communications , 2018 , 9 : 1305 .

MORISHITA M , TAKAHASHI Y , MATSUMOTO A , et al . Exosome-based tumor antigens-adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA [J ] . Biomaterials , 2016 , 111 : 55 - 65 .

ZHANG P F , LIU G , CHEN X Y . Nanobiotechnology: Cell membrane-based delivery systems [J ] . Nano Today , 2017 , 13 : 7 - 9 .

ZHANG P F , CHEN Y X , ZENG Y , et al . Virus-mimetic nanovesicles as a versatile antigen-delivery system [J ] . Proceedings of the National Academy of Sciences of the United States of America , 2015 , 112 ( 45 ): E6129 - E6138 .

LIU X , YUAN L Z , ZHANG L , et al . Bioinspired artificial nanodecoys for Hepatitis B virus [J ] . Angewandte Chemie International Edition , 2018 , 57 ( 38 ): 12499 - 12503 .

ZHANG X J , XU Q B , ZI Z K , et al . Programmable extracellular vesicles for macromolecule delivery and genome modifications [J ] . Developmental Cell , 2020 , 55 ( 6 ): 784 - 801.e9 .

LÜ P , LIU X , CHEN X M , et al . Genetically engineered cell membrane nanovesicles for oncolytic adenovirus delivery: a versatile platform for cancer virotherapy [J ] . Nano Letters , 2019 , 19 ( 5 ): 2993 - 3001 .

RICHTER M , VADER P , FUHRMANN G . Approaches to surface engineering of extracellular vesicles [J ] . Advanced Drug Delivery Reviews , 2021 , 173 : 416 - 426 .

CHEN L X , VALENTINE J L , HUANG C J , et al . Outer membrane vesicles displaying engineered glycotopes elicit protective antibodies [J ] . Proceedings of the National Academy of Sciences of the United States of America , 2016 , 113 ( 26 ): E3609 - E3618 .

GUJRATI V , KIM S , KIM S H , et al . Bioengineered bacterial outer membrane vesicles as cell-specific drug-delivery vehicles for cancer therapy [J ] . ACS Nano , 2014 , 8 ( 2 ): 1525 - 1537 .

LI Y , ZHAO R , CHENG K , et al . Bacterial outer membrane vesicles presenting programmed death 1 for improved cancer immunotherapy via immune activation and checkpoint inhibition [J ] . ACS Nano , 2020 : 2020 Nov24.

WEI X L , ZHANG G , RAN D N , et al . T-cell-mimicking nanoparticles can neutralize HIV infectivity [J ] . Advanced Materials , 2018 , 30 ( 45 ): 1802233 .

WANG C , WANG S B , CHEN Y , et al . Membrane nanoparticles derived from ACE2-rich cells block SARS-CoV-2 infection [J ] . ACS Nano , 2021 , 15 ( 4 ): 6340 - 6351 .

MENG Q F , ZHAO Y Y , DONG C B , et al . Genetically programmable fusion cellular vesicles for cancer immunotherapy [J ] . Angewandte Chemie International Edition , 2021 , 60 ( 50 ): 26320 - 26326 .

XU Z X , TSAI H I , XIAO Y M , et al . Engineering programmed death ligand-1/cytotoxic T-lymphocyte-associated antigen-4 dual-targeting nanovesicles for immunosuppressive therapy in transplantation [J ] . ACS Nano , 2020 , 14 ( 7 ): 7959 - 7969 .

LI L Y , MIAO Q W , MENG F Q , et al . Genetic engineering cellular vesicles expressing CD64 as checkpoint antibody carrier for cancer immunotherapy [J ] . Theranostics , 2021 , 11 ( 12 ): 6033 - 6043 .

ZHANG X D , WANG C , WANG J Q , et al . PD-1 blockade cellular vesicles for cancer immunotherapy [J ] . Advanced Materials , 2018 , 30 ( 22 ): 1707112 .

PANG X , LIU X , CHENG Y , et al . Sono-immunotherapeutic nanocapturer to combat multidrug-resistant bacterial infections [J ] . Advanced Materials , 2019 , 31 ( 35 ): 1902530 .

CHEN Z W , WANG Z J , GU Z . Bioinspired and biomimetic nanomedicines [J ] . Accounts of Chemical Research , 2019 , 52 ( 5 ): 1255 - 1264 .

ZHANG X D , WANG J Q , CHEN Z W , et al . Engineering PD-1-presenting platelets for cancer immunotherapy [J ] . Nano Letters , 2018 , 18 ( 9 ): 5716 - 5725 .

MAUSE S F , VON HUNDELSHAUSEN P , ZERNECKE A , et al . Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium [J ] . Arteriosclerosis, Thrombosis, and Vascular Biology , 2005 , 25 ( 7 ): 1512 - 1518 .

WANG C , SUN W J , YE Y Q , et al . In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy [J ] . Nature Biomedical Engineering , 2017 , 1 : 11 .

HU Q Y , SUN W J , WANG J Q , et al . Conjugation of haematopoietic stem cells and platelets decorated with anti-PD-1 antibodies augments anti-leukaemia efficacy [J ] . Nature Biomedical Engineering , 2018 , 2 ( 11 ): 831 - 840 .

ZHANG X D , KANG Y , WANG J Q , et al . Engineered PD-L1-expressing platelets reverse new-onset type 1 diabetes [J ] . Advanced Materials , 2020 , 32 ( 26 ): 1907692 .

EDMUNDSON M C , CAPENESS M , HORSFALL L . Exploring the potential of metallic nanoparticles within synthetic biology [J ] . New Biotechnology , 2014 , 31 ( 6 ): 572 - 578 .

PRINDLE A , SAMAYOA P , RAZINKOV I , et al . A sensing array of radically coupled genetic 'biopixels' [J ] . Nature , 2012 , 481 ( 7379 ): 39 - 44 .

JEWETT M C , PATOLSKY F . Nanobiotechnology: synthetic biology meets materials science [J ] . Current Opinion in Biotechnology , 2013 , 24 ( 4 ): 551 - 554 .

WANG J , LI Y Y , NIE G J . Multifunctional biomolecule nanostructures for cancer therapy [J ] . Nature Reviews Materials , 2021 , 6 ( 9 ): 766 - 783 .

WANG Z G , DING B Q . Engineering DNA self-assemblies as templates for functional nanostructures [J ] . Accounts of Chemical Research , 2014 , 47 ( 6 ): 1654 - 1662 .

DEY S , FAN C H , GOTHELF K V , et al . DNA origami [J ] . Nature Reviews Methods Primers , 2021 , 1 : 13 .

KE Y G , ONG L L , SHIH W M , et al . Three-dimensional structures self-assembled from DNA bricks [J ] . Science , 2012 , 338 ( 6111 ): 1177 - 1183 .

SEEMAN N C , SLEIMAN H F . DNA nanotechnology [J ] . Nature Reviews Materials , 2018 , 3 : 17068 .

施茜 , 吴园园 , 杨洋 . DNA 纳米技术与合成生物学 [J ] . 合成生物学 , 2022 , 3 ( 2 ): 302 - 319 .

SHI Qian , WU Yuanyuan , YANG yang . DNA nanotechnology and synthetic biology [J ] . Synthetic Biology Journal , 2022 , 3 ( 2 ): 302 - 319 .

LI S P , JIANG Q , LIU S L , et al . A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo [J ] . Nature Biotechnology , 2018 , 36 ( 3 ): 258 - 264 .

LIU S L , JIANG Q , ZHAO X , et al . A DNA nanodevice-based vaccine for cancer immunotherapy [J ] . Nature Materials , 2021 , 20 ( 3 ): 421 - 430 .

KE G L , LIU M H , JIANG S X , et al . Directional regulation of enzyme pathways through the control of substrate channeling on a DNA origami scaffold [J ] . Angewandte Chemie , 2016 , 128 ( 26 ): 7609 - 7612 .

YAO G B , ZHANG F , WANG F , et al . Meta-DNA structures [J ] . Nature Chemistry , 2020 , 12 ( 11 ): 1067 - 1075 .

HSIA Y , BALE J B , GONEN S , et al . Design of a hyperstable 60-subunit protein icosahedron [J ] . Nature , 2016 , 535 ( 7610 ): 136 - 139 .

GU C K , ZHANG T , LÜ C Y , et al . His-mediated reversible self-assembly of ferritin nanocages through two different switches for encapsulation of cargo molecules [J ] . ACS Nano , 2020 , 14 ( 12 ): 17080 - 17090 .

HARTZELL E J , LIESER R M , SULLIVAN M O , et al . Modular hepatitis B virus-like particle platform for biosensing and drug delivery [J ] . ACS Nano , 2020 , 14 ( 10 ): 12642 - 12651 .

KIM E Y , TULLMAN-ERCEK D . Engineering nanoscale protein compartments for synthetic organelles [J ] . Current Opinion in Biotechnology , 2013 , 24 ( 4 ): 627 - 632 .

EDLINGER C , EINFALT T , SPULBER M , et al . Biomimetic strategy to reversibly trigger functionality of catalytic nanocompartments by the insertion of pH-responsive biovalves [J ] . Nano Letters , 2017 , 17 ( 9 ): 5790 - 5798 .

YU J C , QIAN C G , ZHANG Y Q , et al . Hypoxia and H 2 O 2 dual-sensitive vesicles for enhanced glucose-responsive insulin delivery [J ] . Nano Letters , 2017 , 17 ( 2 ): 733 - 739 .

CHEN Z W , WANG J Q , SUN W J , et al . Synthetic beta cells for fusion-mediated dynamic insulin secretion [J ] . Nature Chemical Biology , 2018 , 14 ( 1 ): 86 - 93 .

PETERS R J R W , MARGUET M , MARAIS S , et al . Cascade reactions in multicompartmentalized polymersomes [J ] . Angewandte Chemie , 2014 , 126 ( 1 ): 150 - 154 .

XU C , HU S , CHEN X Y . Artificial cells: from basic science to applications [J ] . Materials Today , 2016 , 19 ( 9 ): 516 - 532 .

KÜCHLER A , YOSHIMOTO M , LUGINBÜHL S , et al . Enzymatic reactions in confined environments [J ] . Nature Nanotechnology , 2016 , 11 ( 5 ): 409 - 420 .

JO S M , WURM F R , LANDFESTER K . Biomimetic cascade network between interactive multicompartments organized by enzyme-loaded silica nanoreactors [J ] . ACS Applied Materials & Interfaces , 2018 , 10 ( 40 ): 34230 - 34237 .

CHEN F M , ZANG Z S , CHEN Z , et al . Nanophotosensitizer-engineered Salmonella bacteria with hypoxia targeting and photothermal-assisted mutual bioaccumulation for solid tumor therapy [J ] . Biomaterials , 2019 , 214 : 119226 .

ZHENG D W , CHEN Y , LI Z H , et al . Optically-controlled bacterial metabolite for cancer therapy [J ] . Nature Communications , 2018 , 9 : 1680 .

FELFOUL O , MOHAMMADI M , TAHERKHANI S , et al . Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions [J ] . Nature Nanotechnology , 2016 , 11 ( 11 ): 941 - 947 .

FORBES N S . Engineering the perfect (bacterial) cancer therapy [J ] . Nature Reviews Cancer , 2010 , 10 ( 11 ): 785 - 794 .

AKIN D , STURGIS J , RAGHEB K , et al . Bacteria-mediated delivery of nanoparticles and cargo into cells [J ] . Nature Nanotechnology , 2007 , 2 ( 7 ): 441 - 449 .

BOURDEAU R W , LEE-GOSSELIN A , LAKSHMANAN A , et al . Acoustic reporter genes for noninvasive imaging of microorganisms in mammalian hosts [J ] . Nature , 2018 , 553 ( 7686 ): 86 - 90 .

DENG X Y , YANG W B , SHAO Z W , et al . Genetically modified bacteria for targeted phototherapy of tumor [J ] . Biomaterials , 2021 , 272 : 120809 .

DEWHIRST M W , SECOMB T W . Transport of drugs from blood vessels to tumour tissue [J ] . Nature Reviews Cancer , 2017 , 17 ( 12 ): 738 - 750 .

SUH S , JO A , TRAORE M A , et al . Nanoscale bacteria-enabled autonomous drug delivery system (NanoBEADS) enhances intratumoral transport of nanomedicine [J ] . Advanced Science , 2019 , 6 ( 3 ): 1801309 .

FAN J X , PENG M Y , WANG H , et al . Engineered bacterial bioreactor for tumor therapy via Fenton-like reaction with localized H 2 O 2 generation [J ] . Advanced Materials , 2019 , 31 ( 16 ): 1808278 .

XING J H , YIN T , LI S M , et al . Sequential magneto-actuated and optics-triggered biomicrorobots for targeted cancer therapy [J ] . Advanced Functional Materials , 2021 , 31 ( 11 ): 2008262 .

NEWICK K , O'BRIEN S , MOON E , et al . CAR T cell therapy for solid tumors [J ] . Annual Review of Medicine , 2017 , 68 : 139 - 152 .

MAUDE S L , LAETSCH T W , BUECHNER J , et al . Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia [J ] . The New England Journal of Medicine , 2018 , 378 ( 5 ): 439 - 448 .

TANG L , ZHENG Y R , MELO M B , et al . Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery [J ] . Nature Biotechnology , 2018 , 36 ( 8 ): 707 - 716 .

NIE W D , WEI W , ZUO L P , et al . Magnetic nanoclusters armed with responsive PD-1 antibody synergistically improved adoptive T-cell therapy for solid tumors [J ] . ACS Nano , 2019 , 13 ( 2 ): 1469 - 1478 .

HAO M X , HOU S Y , LI W S , et al . Combination of metabolic intervention and T cell therapy enhances solid tumor immunotherapy [J ] . Science Translational Medicine , 2020 , 12 ( 571 ): eaaz6667 .

KIM G B , ARAGON-SANABRIA V , RANDOLPH L , et al . High-affinity mutant Interleukin-13 targeted CAR T cells enhance delivery of clickable biodegradable fluorescent nanoparticles to glioblastoma [J ] . Bioactive Materials , 2020 , 5 ( 3 ): 624 - 635 .

SIRIWON N , KIM Y J , SIEGLER E , et al . CAR-T cells surface-engineered with drug-encapsulated nanoparticles can ameliorate intratumoral T-cell hypofunction [J ] . Cancer Immunology Research , 2018 , 6 ( 7 ): 812 - 824 .

CHEN Q , HU Q Y , DUKHOVLINOVA E , et al . Photothermal therapy promotes tumor infiltration and antitumor activity of CAR T cells [J ] . Advanced Materials , 2019 , 31 ( 23 ): 1900192 .

HU Q , LI H , ARCHIBONG E , et al . Inhibition of post-surgery tumour recurrence via a hydrogel releasing CAR-T cells and anti-PDL1-conjugated platelets [J ] . Nature Biomedical Engineering , 2021 , 5 ( 9 ): 1038 - 1047 .

HARMSEN S , MEDINE E I , MOROZ M , et al . A dual-modal PET/near infrared fluorescent nanotag for long-term immune cell tracking [J ] . Biomaterials , 2021 , 269 : 120630 .

UJÉDA L . Nanotechnology and synthetic biology: the ambiguity of the nano-bio convergence [J ] . Philosophia Scientae , 2019 , 23 ( 23-1 ): 57 - 72 .

PURNICK P E , WEISS R . The second wave of synthetic biology: from modules to systems [J ] . Nature Reviews Molecular Cell Biology , 2009 , 10 ( 6 ): 410 - 422 .

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

合成生物学赋能细胞膜纳米颗粒的精准诊疗

基于极端微生物的生物制造